K

Kindly MD Inc
NASDAQ:KDLY

Watchlist Manager
Kindly MD Inc
NASDAQ:KDLY
Watchlist
Price: 10.9 USD -5.71% Market Closed
Market Cap: $120.8m

Kindly MD Inc
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Kindly MD Inc
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
K
Kindly MD Inc
NASDAQ:KDLY
Research & Development
-$377.7k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Quest Diagnostics Inc
NYSE:DGX
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
CVS Health Corp
NYSE:CVS
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cigna Corp
NYSE:CI
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Laboratory Corporation of America Holdings
NYSE:LH
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Guardant Health Inc
NASDAQ:GH
Research & Development
-$359.5m
CAGR 3-Years
-2%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
No Stocks Found

Kindly MD Inc
Glance View

Market Cap
120.8m USD
Industry
Health Care

Kindly MD, Inc. provided healthcare services. The company is headquartered in Salt Lake City, Utah and currently employs 23 full-time employees. The company went IPO on 2024-05-31. The firm offers direct health care to patients, integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a fee-for-service basis. The firm offers evaluation and management, including, but not limited to, chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, medically managed weight loss, and hormone therapy. The firm also collects data focused on why and how patients turn to alternative treatments to reduce prescription medication use and addiction. The firm captures all relevant data points to assist and appropriately treat each individual patient.

KDLY Intrinsic Value
HIDDEN
Show

See Also

What is Kindly MD Inc's Research & Development?
Research & Development
-377.7k USD

Based on the financial report for Dec 31, 2024, Kindly MD Inc's Research & Development amounts to -377.7k USD.

Back to Top